BASIX® Performance Protocol combines three compounds that act on complementary growth, recovery, and tissue signaling pathways, creating a multi-layered research model focused on cellular repair, structural integrity, and performance adaptation.

BPC-157 is a high-purity research peptide derived from gastric proteins, studied for its role in angiogenesis and nitric oxide signaling pathways, with implications in tissue repair and inflammatory modulation. Preclinical studies have demonstrated its ability to promote healing across muscle, tendon, ligament, and gastrointestinal models.

TB-500 is a synthetic peptide fragment of thymosin beta-4 studied for its role in actin regulation and cellular migration pathways, with implications in systemic tissue repair and regeneration. Research models have examined its effects on wound healing, inflammation, and cell differentiation.

2X Blend (CJC-1295 No DAC / Ipamorelin) is a research peptide combination studied for its role in growth hormone signaling, endocrine regulation, and metabolic pathways. It has been explored in both clinical and preclinical research for its interaction with growth hormone–releasing hormone (GHRH) and ghrelin receptor pathways, including its potential influence on pulsatile growth hormone release, IGF-1 signaling, and regulatory endocrine processes.